NCT01560117View on ClinicalTrials.gov

Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2010

Conditions
Follicular T-NHL LymphomaRituximab Maintenance
Interventions
DRUG

Rituximab

Rituximab 375 mg/m2 i.v. every 2 months for 24 months

All Listed Sponsors
lead

Arbeitsgemeinschaft medikamentoese Tumortherapie

OTHER

NCT01560117 - Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma | Biotech Hunter | Biotech Hunter